The ZURICH team continue their discussion around DNA and microRNA methylation and touch on the reasons why it is so difficult to treat psychiatric disorders…
Meeting 1 Episode 6 – Another Epigenetic Mechanism
Meeting 1 Episode 5 – Some Epigenetic Markers
The meeting begins to get “technical” as Isabelle and Renaud discuss the markers and mechanisms involved in Transgenerational Epigenetic Inheritance (TEI)…
Meeting 1 Episode 4 – Useful and Constructive
Isabelle reveals the advantages participating in SYNERGIES and Cecilia evokes the problems she has with taking her medication…
Meeting 1 Episode 3 – Metabolising the Dose
The ambition of the MAPS project is to match drugs and doses to patient metabolisms – Katie thinks that sounds too good to be true…
Meeting 1 Episode 2 – Early Days
The group discusses the logistics of getting swabs and getting well…
Meeting 1 Episode 1 – The Project
Sean and the group discuss the origins of the MAPS project and coin a catchphrase in the process…
Meeting 1 Episode 6 – PLEXRP first impressions – Jacqueline
What happens next? Jacqueline reflects on the lack of feedback or continuity in scientific trials…
Meeting 1 Episode 5 – PLEXRP first impressions – Alexandre
No navel gazing here. Alexandre is pleasantly surprised by the scope of the ethics consultation…
Meeting 1 Episode 3 – a Question of Ethics
Getting it right. Kristina emphasises the importance of ethics in scientific research…
Meeting 1 Episode 2 – Enlightened Consent
How long is too long? Jacqueline wants to know how do you go about ensuring participants in this trial really do give their “enlightened consent”?